FDA Approved 35 New Innovative Drugs in Fiscal 2011

The U.S. Food and Drug Administration (FDA) says it approved 35 new medicines in the fiscal year ended September 30, 2011. This is among the highest number of approvals in the past decade, surpassed only by 2009, when 37 drugs were approved. The FDA provided details of the drug approvals in a report released this week. The approved drugs include two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin’s lymphoma in 30 years; and the first new drug for lupus in 50 years. Seven of the new medicines are major...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers